» Articles » PMID: 21472114

Potential Beneficial Effects of Butyrate in Intestinal and Extraintestinal Diseases

Overview
Specialty Gastroenterology
Date 2011 Apr 8
PMID 21472114
Citations 535
Authors
Affiliations
Soon will be listed here.
Abstract

The multiple beneficial effects on human health of the short-chain fatty acid butyrate, synthesized from non-absorbed carbohydrate by colonic microbiota, are well documented. At the intestinal level, butyrate plays a regulatory role on the transepithelial fluid transport, ameliorates mucosal inflammation and oxidative status, reinforces the epithelial defense barrier, and modulates visceral sensitivity and intestinal motility. In addition, a growing number of studies have stressed the role of butyrate in the prevention and inhibition of colorectal cancer. At the extraintestinal level, butyrate exerts potentially useful effects on many conditions, including hemoglobinopathies, genetic metabolic diseases, hypercholesterolemia, insulin resistance, and ischemic stroke. The mechanisms of action of butyrate are different; many of these are related to its potent regulatory effects on gene expression. These data suggest a wide spectrum of positive effects exerted by butyrate, with a high potential for a therapeutic use in human medicine.

Citing Articles

The Relationship Between Fiber Intake and Gut Bacterial Diversity and Composition During the Third Trimester of Pregnancy.

Schwartz L, Ladouceur J, Russell M, Xie S, Bu S, Kerver J Nutrients. 2025; 17(5).

PMID: 40077643 PMC: 11901921. DOI: 10.3390/nu17050773.


Gut Metagenome Reveals the Microbiome Signatures in Tibetan and Black Pigs.

Bai X, Gu Y, Li D, Li M Animals (Basel). 2025; 15(5).

PMID: 40076036 PMC: 11899681. DOI: 10.3390/ani15050753.


Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.

Zhang H, Tian Y, Xu C, Chen M, Xiang Z, Gu L Cell Death Discov. 2025; 11(1):78.

PMID: 40011436 PMC: 11865559. DOI: 10.1038/s41420-025-02364-5.


Fecal Short-Chain Fatty Acids Are Associated with Obesity in Gestational Diabetes.

Molan K, Ambrozic Avgustin J, Likar M, Pongrac Barlovic D, Zgur Bertok D, Starcic Erjavec M Biomedicines. 2025; 13(2).

PMID: 40002799 PMC: 11853429. DOI: 10.3390/biomedicines13020387.


Gut microbiota in Crohn's disease pathogenesis.

Ozbey D, Saribas S, Kocazeybek B World J Gastroenterol. 2025; 31(6):101266.

PMID: 39958442 PMC: 11752695. DOI: 10.3748/wjg.v31.i6.101266.


References
1.
Park Y, Hunter D, Spiegelman D, Bergkvist L, Berrino F, van den Brandt P . Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005; 294(22):2849-57. DOI: 10.1001/jama.294.22.2849. View

2.
Perrine S, Ginder G, Faller D, Dover G, Ikuta T, Witkowska H . A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993; 328(2):81-6. DOI: 10.1056/NEJM199301143280202. View

3.
Burkitt D . Epidemiology of cancer of the colon and rectum. 1971. Dis Colon Rectum. 1993; 36(11):1071-82. DOI: 10.1007/BF02047303. View

4.
Fukumoto S, Tatewaki M, Yamada T, Fujimiya M, Mantyh C, Voss M . Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol. 2003; 284(5):R1269-76. DOI: 10.1152/ajpregu.00442.2002. View

5.
Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain J . Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis. 2009; 16(4):684-95. DOI: 10.1002/ibd.21108. View